Levetiracetam Versus Fosphenytoin Infusions as Second-Line Treatment for Pediatric Status Epilepticus: A Multicenter Study Examining Effectiveness, Tolerability, and Ease of Use.
- DOI
- 10.1007/s40272-025-00709-2
- Published
- 2025 Sep
- Container
- Paediatric drugs
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40272-025-00709-2,
title = {Levetiracetam Versus Fosphenytoin Infusions as Second-Line Treatment for Pediatric Status Epilepticus: A Multicenter Study Examining Effectiveness, Tolerability, and Ease of Use.},
author = {Hornard A and Severac F and Laugel V and Abi Wardé MT and Bansept C and de Feraudy Y and Haupt S and Spitz MA and Eyer D and de Saint Martin A and Baer S},
year = {2025},
journal = {Paediatric drugs},
doi = {10.1007/s40272-025-00709-2},
url = {https://doi.org/10.1007/s40272-025-00709-2}
}RIS
TY - JOUR TI - Levetiracetam Versus Fosphenytoin Infusions as Second-Line Treatment for Pediatric Status Epilepticus: A Multicenter Study Examining Effectiveness, Tolerability, and Ease of Use. AU - Hornard A AU - Severac F AU - Laugel V AU - Abi Wardé MT AU - Bansept C AU - de Feraudy Y AU - Haupt S AU - Spitz MA AU - Eyer D AU - de Saint Martin A AU - Baer S PY - 2025 JO - Paediatric drugs DO - 10.1007/s40272-025-00709-2 UR - https://doi.org/10.1007/s40272-025-00709-2 ER -
APA
A, H., F, S., V, L., MT, A. W., C, B., Y, D. F., S, H., MA, S., D, E., A, D. S. M., & S, B. (2025). Levetiracetam Versus Fosphenytoin Infusions as Second-Line Treatment for Pediatric Status Epilepticus: A Multicenter Study Examining Effectiveness, Tolerability, and Ease of Use.. Paediatric drugs. https://doi.org/10.1007/s40272-025-00709-2
Source records
- pubmed · retrieved 2026-09-26T09:13:10.880Z